Journal of Pharmaceutical Care & Health Systems
Open Access

Hypercalcemia Management in Chronic Kidney Disease Patients

Armani Marvin^{* *}Correspondence: Armani Marvin, Department of Clinical Pharmacy and Therapeutic, Applied Science Private University, Amman 11931-166, Jordan, Email:

Author info »

About the Study

Treatment for hypercalcemia have to be aimed both at lowering the serum calcium concentration and, if possible, treating the underlying disease. Effective treatments reduce serum calcium through inhibiting bone resorption, increasing urinary calcium excretion, or decreasing intestinal calcium absorption. The most efficient preference varies with the cause and severity of hypercalcemia. The treatment of hypercalcemia with emphasis on the control of hypercalcemia in sufferers with malignant disease.

Serum Calcium: Calcium in serum is bound to proteins, mainly albumin. As a result, total serum calcium concentrations in sufferers with low or excessive serum albumin levels might not appropriately reflect the physiologically vital ionized (or free) calcium concentration. As an example, in sufferers with hypoalbuminemia, total serum calcium concentration can be normal while serum ionized calcium is elevated. Alternatively, sufferers with hyperalbuminemia due to extreme volume depletion and rare sufferers with multiple myeloma, who've a calcium-binding paraprotein, have elevated protein binding of calcium. This can cause an elevation in the serum total calcium concentration without any rise in the serum ionized calcium concentration. This phenomenon is known as pseudo hypercalcemia (or factitious hypercalcemia) for the reason that patient has a normal ionized serum calcium concentration. In sufferers with hypoalbuminemia or hyperalbuminemia, the measured serum calcium concentration ought to be corrected for the abnormality in albumin or for standard units. If a laboratory known to measure ionized calcium reliably is available, a few authorities opt to measure the serum ionized calcium in this situation. Hypercalcemia can be related to a spectrum of clinical manifestations, starting from few or no signs in sufferers with mild chronic hypercalcemia to severe obtundation and coma.

The degree of hypercalcemia, along with the rate of rise of serum calcium concentration, often determines signs and symptoms and the urgency of therapy. The healing technique ought to reflect these differences. Patients with asymptomatic or mildly symptomatic (eg, constipation) hypercalcemia (calcium 14 mg/dL require treatment, irrespective of symptoms. There are three different stages of hypercalcemia: Mild hypercalcemia-Patients with asymptomatic or mildly symptomatic hypercalcemia (total albumin-corrected calcium one thousand mg/day). Adequate hydration (at least six to eight glasses of water per day) is suggested to reduce the chance of nephrolithiasis. Additional therapy relies upon the cause of the hypercalcemia. Moderate hypercalcemia-Asymptomatic or mildly symptomatic people with chronic moderate hypercalcemia (total albumin-corrected calcium between 12 and 14 mg/dL won't require instant therapy. However, they ought to follow the same precautions described above for mild hypercalcemia. It is vital to be aware that an acute rise to these concentrations may also cause marked changes in sensorium, which requires greater competitive therapy. In those sufferers, we normally treat with saline hydration and bisphosphonates, as described for severe hypercalcemia. Severe hypercalcemia-Patients with total albumin-corrected calcium >14 mg/dL require more competitive remedy.